{"id":"co-trimoxazole-20","safety":{"commonSideEffects":[{"rate":"3-6","effect":"Rash"},{"rate":"3-5","effect":"Nausea"},{"rate":"2-4","effect":"Vomiting"},{"rate":"2-4","effect":"Diarrhea"},{"rate":"1-2","effect":"Hyperkalemia"},{"rate":"0.1-0.5","effect":"Stevens-Johnson syndrome"},{"rate":"1-2","effect":"Hepatotoxicity"}]},"_chembl":{"chemblId":"CHEMBL58061","moleculeType":"Small molecule","molecularWeight":"543.61"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Sulfamethoxazole inhibits dihydropteroate synthase, while trimethoprim inhibits dihydrofolate reductase. Together, they block the bacterial synthesis of dihydrofolate and tetrahydrofolate, nucleotides essential for DNA synthesis. This synergistic dual inhibition is bactericidal and provides broad-spectrum coverage against many gram-positive and gram-negative organisms.","oneSentence":"Co-trimoxazole is a fixed-dose combination of sulfamethoxazole and trimethoprim that inhibits bacterial folate synthesis at two sequential steps, preventing DNA replication.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:30:25.551Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Urinary tract infections"},{"name":"Respiratory tract infections"},{"name":"Otitis media"},{"name":"Pneumocystis jirovecii pneumonia (PCP) prophylaxis and treatment"},{"name":"Toxoplasmosis"}]},"trialDetails":[{"nctId":"NCT07485010","phase":"PHASE2","title":"Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Queensland","startDate":"2027-04","conditions":"Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection, Non-Tuberculous Mycobacterial (NTM) Infections","enrollment":300},{"nctId":"NCT01631617","phase":"PHASE2","title":"Effects of Treatments on Atopic Dermatitis","status":"RECRUITING","sponsor":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","startDate":"2012-09-18","conditions":"Eczema, Dermatitis, Skin Diseases, Genetic","enrollment":130},{"nctId":"NCT07451171","phase":"PHASE2","title":"Comparative Efficacy of Antibiotics for Small Intestine Bacterial Overgrowth in Bangladeshi Children","status":"NOT_YET_RECRUITING","sponsor":"University of Virginia","startDate":"2026-04","conditions":"Small Intestine Bacterial Overgrowth","enrollment":60},{"nctId":"NCT05544565","phase":"PHASE4","title":"3-day IV Antibiotic Treatment Versus 3-day IV Followed by 7-day Oral Antibiotic Treatment for AP in Children","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-03-22","conditions":"Pyelonephritis Acute","enrollment":480},{"nctId":"NCT03915366","phase":"PHASE2, PHASE3","title":"Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia","status":"COMPLETED","sponsor":"Hospital Universitario 12 de Octubre","startDate":"2020-03-01","conditions":"Pneumonia, HIV/AIDS, Tuberculosis","enrollment":563},{"nctId":"NCT04310930","phase":"PHASE2, PHASE3","title":"Finding the Optimal Regimen for Mycobacterium Abscessus Treatment","status":"RECRUITING","sponsor":"The University of Queensland","startDate":"2020-03-02","conditions":"Pulmonary Disease Due to Mycobacteria (Diagnosis)","enrollment":300},{"nctId":"NCT05835479","phase":"PHASE2","title":"Rezafungin for Treatment of Pneumocystis Pneumonia in HIV Adults","status":"RECRUITING","sponsor":"Mundipharma Research Limited","startDate":"2023-11-14","conditions":"Pneumocystis Pneumonia","enrollment":50},{"nctId":"NCT04341155","phase":"PHASE2","title":"Dexamethasone for Cerebral Toxoplasmosis","status":"RECRUITING","sponsor":"Universitas Padjadjaran","startDate":"2021-04-16","conditions":"Toxoplasmosis, Cerebral","enrollment":138},{"nctId":"NCT05843968","phase":"PHASE2","title":"Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil in Children With Steroid-dependent Nephrotic Syndrome","status":"RECRUITING","sponsor":"Children's Hospital of Chongqing Medical University","startDate":"2023-01-29","conditions":"Nephrotic Syndrome in Children","enrollment":46},{"nctId":"NCT05454345","phase":"PHASE3","title":"Sitafloxacin-containing Regimens for Shortening Tuberculosis Treatment","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2022-10-01","conditions":"Tuberculosis, Pulmonary","enrollment":620},{"nctId":"NCT01420341","phase":"PHASE4","title":"Co-trimoxazole as Maintenance Therapy for Melioidosis","status":"COMPLETED","sponsor":"Khon Kaen University","startDate":"2011-08","conditions":"Melioidosis","enrollment":667},{"nctId":"NCT00080119","phase":"PHASE2, PHASE3","title":"Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV","status":"TERMINATED","sponsor":"International Maternal Pediatric Adolescent AIDS Clinical Trials Group","startDate":"2004-02","conditions":"HIV Infection, Tuberculosis, Pneumocystis Jiroveci Pneumonia","enrollment":1354},{"nctId":"NCT03395249","phase":"PHASE1","title":"Phase 1 Study of Safety, Tolerability and Pharmacokinetics of SPR994","status":"COMPLETED","sponsor":"Spero Therapeutics","startDate":"2017-10-20","conditions":"Healthy Volunteers","enrollment":124},{"nctId":"NCT01042704","phase":"PHASE1","title":"Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma","status":"COMPLETED","sponsor":"Robert Redner, MD","startDate":"2008-02","conditions":"Myeloma","enrollment":29},{"nctId":"NCT00023244","phase":"PHASE2","title":"Steroid Withdrawal in Pediatric Kidney Transplant Recipients","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2001-01","conditions":"End-Stage Renal Disease","enrollment":274},{"nctId":"NCT00522821","phase":"PHASE4","title":"Treatment of Deficient Subclass or Anti-polysaccharide Antibody Response","status":"COMPLETED","sponsor":"Prothya Biosolutions","startDate":"2007-11","conditions":"IgG Deficiency, Infections","enrollment":55},{"nctId":"NCT00109837","phase":"PHASE2","title":"S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"2005-04","conditions":"Leukemia","enrollment":79},{"nctId":"NCT00586014","phase":"PHASE2","title":"High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma","status":"COMPLETED","sponsor":"Duke University","startDate":"1997-05","conditions":"Multiple Myeloma","enrollment":91},{"nctId":"NCT00527800","phase":"PHASE3","title":"Interactions Between HIV and Malaria in African Children","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2007-08","conditions":"Malaria, HIV Infections","enrollment":351},{"nctId":"NCT00002571","phase":"PHASE2","title":"SWOG-9320 Combination Chemotherapy, Radiation Therapy, and Antiviral Therapy in Treating Patients With AIDS-Related Lymphoma","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"1994-06","conditions":"Lymphoma","enrollment":52},{"nctId":"NCT00676130","phase":"NA","title":"Study of New Antibiotic Regimen for the Treatment of Uncomplicated Cellulitis in Emergency Department Patients","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2007-05","conditions":"Cellulitis","enrollment":153},{"nctId":"NCT00720811","phase":"NA","title":"Assessment of Use of Rapid Diagnostic Testing in the Context of Home Management With ACTs","status":"COMPLETED","sponsor":"Mbarara University of Science and Technology","startDate":"2009-10","conditions":"Malaria, Pneumonia","enrollment":6456},{"nctId":"NCT01114048","phase":"PHASE2","title":"Early Response-adapted Intensification of Induction Chemotherapy in Patients With Newly Diagnosed Multiple Myeloma (MM)","status":"UNKNOWN","sponsor":"Chonnam National University Hospital","startDate":"2010-03","conditions":"Multiple Myeloma","enrollment":78},{"nctId":"NCT00396526","phase":"PHASE3","title":"ICMR-Indiaclen Trial on Amoxycillin vs Cotrimoxazole for Non-Severe Pneumonia","status":"COMPLETED","sponsor":"King George's Medical University","startDate":"2004-04","conditions":"Non-Severe Pneumonia, Under-Fives, Children","enrollment":2000}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Co-trimoxazole 20","genericName":"Co-trimoxazole 20","companyName":"Khon Kaen University","companyId":"khon-kaen-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Co-trimoxazole is a fixed-dose combination of sulfamethoxazole and trimethoprim that inhibits bacterial folate synthesis at two sequential steps, preventing DNA replication. Used for Urinary tract infections, Respiratory tract infections, Otitis media.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}